Psychiatry and Neurology, Neurology · Los Gatos, CA
NPI
1780871186
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
800 Pollard Rd, Suite C30
Los Gatos, CA, 95032
Phone (408) 376-0316
Medicare paid, 2024
$273K
28,669 services
Medicare patients, 2024
266
Average age 75
Drug cost, 2024
$1.6M
4,107 prescriptions
Company payments, 2025
$2,942
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Peter T Lin was code J0585 (injection, onabotulinumtoxina, 1 unit), 21,905 times for 40 patients. In total Peter T Lin billed 28,669 services in 27 codes, and Medicare paid $273K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-01-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 21,905 | 40 | $4.82 | $106K |
| 99214 Office E&M - Established | Office | 786 | 241 | $110.26 | $87K |
| 95874 Musculoskeletal | Office | 82 | 27 | $79.18 | $6,493 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 82 | 82 | $23.97 | $1,965 |
| 96116 Behavioral Health Services | Office | 71 | 70 | $82.93 | $5,888 |
| 64616 Musculoskeletal | Office | 67 | 22 | $179.95 | $12K |
| 99497 Care Management/Coordination | Office | 67 | 66 | $71.43 | $4,786 |
| 99204 Office E&M - New | Office | 45 | 45 | $141.66 | $6,375 |
| 64612 Musculoskeletal | Office | 44 | 15 | $176.26 | $7,755 |
| 95983 Electrical Nerve Conductivity | Office | 38 | 19 | $42.85 | $1,628 |
| 95984 Electrical Nerve Conductivity | Office | 34 | 14 | $38.06 | $1,294 |
| 99442 Telephone Services | Office | 15 | 12 | $81.93 | $1,229 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 12 | 11 | $52.83 | $634 |
By year: 2022 $247K for 22,775 services; 2023 $242K for 23,892 services; 2024 $273K for 28,669 services.
Medicare prescription drug claims, 2024
In 2024, the drug Peter T Lin prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 743 prescriptions and refills. In total Peter T Lin wrote 4,107 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 743 | 1,694 | 212 | $32K |
| Rytary Carbidopa/Levodopa | 242 | 358 | 43 | $396K |
| Amantadine Amantadine Hcl | 231 | 529 | 75 | $12K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 204 | 470 | 62 | $8,550 |
| Gabapentin Generic | 179 | 405 | 62 | $3,561 |
| Quetiapine Fumarate Generic | 162 | 277 | 40 | $4,216 |
| Neupro Rotigotine | 158 | 216 | 29 | $179K |
| Escitalopram Oxalate Generic | 110 | 171 | 21 | $1,646 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 100 | 220 | 22 | $1,824 |
| Entacapone Generic | 96 | 168 | 26 | $20K |
| Clonazepam Generic | 91 | 107 | 14 | $934 |
| Donepezil Hcl Generic | 79 | 175 | 22 | $1,084 |
| Rivastigmine Rivastigmine Tartrate | 70 | 135 | 19 | $2,307 |
| Nuplazid Pimavanserin Tartrate | 66 | 66 | Under 11 | $285K |
| Rasagiline Mesylate Generic | 63 | 129 | 21 | $14K |
Brand drugs: - claims; generic drugs: 3,303 claims; opioid claims: 32.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Peter T Lin $2,942 ($2,942 in general payments such as food, travel and fees) from 13 companies. The largest payer was ACADIA Pharmaceuticals Inc with $408.
| Company | Payments | Amount |
|---|---|---|
| ACADIA Pharmaceuticals Inc ACAD | 14 | $408 |
| Teva Pharmaceuticals USA, Inc. TEVA | 12 | $399 |
| Abbvie Inc. ABBV | 17 | $398 |
| MDD US Operations, LLC | 16 | $386 |
| Boston Scientific Corporation BSX | 4 | $335 |
| Neurocrine BioSciences, Inc. NBIX | 12 | $302 |
| Pfizer Inc. PFE | 13 | $254 |
| Amneal Pharmaceuticals LLC AMRX | 11 | $183 |
| Merz Pharmaceuticals, LLC | 3 | $124 |
| Lundbeck LLC | 2 | $49.18 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.